Video

Effective Communication in Colorectal Cancer

Effective communication with a patient who has been newly diagnosed with colorectal cancer is critical, says John Marshall, MD. Determining the patient’s level of knowledge about cancer as well as what they would like to know is also important. Establishing objectives during each appointment will help the process, says Marshall, as it is not generally feasible to discuss everything and reach all treatment decisions by the end of their visit.

Understanding the social support system of a patient is also essential, states Cathy Eng, MD, such as who is responsible for assisting the patient and whether they are living with a spouse. Eng also ensures that her patients are comfortable with her speaking to family members. Having an interpreter present is helpful when speaking to patients whose primary language is not English. If that is not possible, low fee dial-in services are available, says Eng.

Related Videos
Haley M. Hill, PA-C, discusses preliminary data for zenocutuzumab in NRG1 fusion–positive non–small cell lung cancer and pancreatic cancer.
Haley M. Hill, PA-C, discusses how physician assistants aid in treatment planning for NRG1-positive non–small cell lung cancer and pancreatic cancer.
Haley M. Hill, PA-C, discusses DNA vs RNA sequencing for genetic testing in non–small cell lung cancer and pancreatic cancer.
Haley M. Hill, PA-C, discusses current approaches and treatment challenges in NRG1-positive non–small cell lung cancer and pancreatic cancer.
Aparna Parikh, MD
Tanios Bekaii-Saab, MD, FACP
Cindy Medina Pabon, MD, assistant professor, Sylvester Cancer Center, University of Miami; assistant lead, GI Cancer Clinical Research, Gastrointestinal Medical Oncology, University of Miami Health Systems
Aparna Parikh, MD, associate professor, medicine, Harvard Medical School; assistant in medicine, Hematology, Oncology, Massachusetts General Hospital; attending oncologist, Tucker Gosnell Center for Gastrointestinal Cancers, the Henri and Belinda Termeer Center for Targeted Therapies
Mohammed Najeeb Al Hallak, MD, MS, and Sakti Chakrabarti, MD, discuss ongoing research in gastrointestinal cancers.
Mohammed Najeeb Al Hallak, MD, MS, and Sakti Chakrabarti, MD, discuss research building upon approved combinations in unresectable hepatocellular carcinoma.